All lots of the Euphoric male enhancement supplement have been voluntarily recalled by Epic Products, LLC after the US Food and Drug Administration (FDA) discovered the presence of undeclared prescription erectile dysfunction products. The product, packaged in one count blister cards, three count...

The US Food and Drug Administration (FDA) has taken steps to restrict the sale and distribution of the Essure device, citing the lack of awareness of the risks and benefits among many women opting for this form of contraception as one of its main concerns. “Based on our review of a growing...

The US Food and Drug Administration (FDA) has approved Crysvita (burosumab) as a treatment for a rare form of inherited rickets. It is the first drug therapy approved as a treatment for x-linked hypophosphatemia (XLH) with evidence of bone disease in children over one year of age and adolescents...

The US Food and Drug Administration (FDA) has permitted marketing of a medical device that utilizes artificial intelligence (AI) to detect certain eye problems related to diabetes. It is the first device of its kind to harness AI to detect diabetic retinopathy considered greater than a mild level...

Adult diabetes may fall into five different categories rather than type 1 and type 2 diabetes, according to new research. A study conducted by researchers at Lund University in Sweden found new classifications for diabetes, each with their own distinct genetics and characteristics. It is hoped the...

The US Food and Drug Administration (FDA) has issued a warning to consumers about unapproved erectile dysfunction drugs advertised nationwide on broadcast and internet radio platforms. The products, advertised on iHeartRadio and other stations, have been advertised as a “healthy man...

Cancer medication Blincyto (blinatumomab) has received accelerated approval as a treatment to reduce the risk of relapse in certain patients with B-cell precursor acute lymphoblastic leukemia (ALL). Under the latest US Food and Drug Administration (FDA) approval, Blincyto is indicated for adults...

The US Food and Drug Administration (FDA) has approved Ilumya (tildrakizumab-asmn) for treating adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. The Sun Pharma drug was granted approval following two Phase 3 clinical trials featuring 926...

In an exciting breakthrough for patients with diabetes, the US Food and Drug Administration (FDA) has authorized the marketing of the Dexcom G6 integrated continuous glucose monitoring system (iCGM). The latest version of the continuous glucose monitoring system is indicated for use by patients...

Bariatric surgery could halve the chance of severely obese teens developing premature heart disease or having a stroke, according to new research. The model presented at the American Heart Association’s Epidemiology and Prevention Lifestyle and Cardiometabolic Health Scientific Sessions 2018...

Improving early diagnosis of Alzheimer’s disease could significantly reduce healthcare costs in the United States, according to a new report from the Alzheimer’s Association. Up to $7.9 trillion could be saved in both health and long-term care expenditure in the United States if more...

The high cost of prescription medication remains a major concern for a significant proportion of Americans, with eight out ten respondents to the latest Kaiser Health Tracking Poll describing prices as “unreasonable”. The results showed a rise in the proportion of the American public...

Obesity and diabetes are significantly more common in the United States than 20 years ago, according to recent data from the National Center for Health Statistics (NCHS). In 1997, under 20 percent of American adults over 20 years of age were classified as obese, a figure that rose to 31.4 percent...

Loud noise levels in American workplaces could be contributing to high cholesterol and high blood pressure levels among workers, according to a recent Centers for Disease Control and Prevention (CDC) study. The analysis published in the American Journal of Industrial Medicine examined the...

Treatment with emicizumab improves the health of patients with hemophilia A and inhibitors to Factor VIII, while simultaneously reducing the cost of treatment. These are the findings of the New England Comparative Effectiveness Public Advisory Council (CEPAC), one of the Institute for Clinical and...

The US Food and Drug Administration (FDA) has approved Adcetris (brentuximab vedotin) as a treatment for certain adult patients with classical Hodgkin lymphoma (cHL). Under the latest approval, the Seattle Genetics drug is indicated for use in combination with chemotherapy as a treatment for...

Annual per patient outpatient pharmacy costs at hospitals participating in the 340B Drug Discount Program are significantly higher than in non-340B hospitals, according to new analysis from the Pharmaceutical Research and Manufacturers of America (PhRMA). The analysis, prepared by Milliman and...

Sanofi and Regeneron Pharmaceuticals announced plans to improve patient access to Praluent (alirocumab) by offering a reduced net price to payers that commit to reducing access barriers for high-risk patients. The company will meet with US health plans to discuss price adjustments and will work...

A new treatment option is available for patients with multi-drug resistant (MDR) HIV following the US Food and Drug Administration’s (FDA) approval of Trogarzo (ibalizumab-uiyk). The medication, developed by TaiMed Biologics USA Corp, is a new form of antiretroviral medication indicated for...

Universal vaccination against the flu could help slow the spread of the disease in the future, according to a recent study into the efficacy of flu vaccines. The clinical trial conducted by GlaxoSmithKline (GSK) examined the efficacy of Fluarix Tetra (inactivated quadrivalent influenza vaccine...